Kinnate Biopharma Inc. (KNTE)
NASDAQ: KNTE
· Real-Time Price · USD
2.65
-0.01 (-0.38%)
At close: Apr 02, 2024, 10:00 PM
Kinnate Biopharma Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.64 | -0.54 | -1.11 | -2.27 | -2.25 | -4.38 | -5.19 | -4.62 | -7.39 | -10.17 | -11.82 | -19.4 |
PEG Ratio | 0.04 | 0.12 | 0.76 | -1.55 | n/a | -0.38 | n/a | -2.77 | -1.4 | -0.62 | -0.53 | -0.67 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.70 | 0.38 | 0.72 | 1.27 | 1.21 | 2.12 | 2.03 | 1.67 | 2.42 | 2.95 | 2.80 | 3.58 |
P/FCF Ratio | -6.43 | -2.58 | -4.81 | -10.24 | -11.31 | -25.46 | -23.03 | -21.39 | -33.32 | -56.87 | -57.95 | -100.76 |
P/OCF Ratio | -6.43 | -2.58 | -4.8 | -10.24 | -11.36 | -25.54 | -23.57 | -23.43 | -34.35 | -56.98 | -58.05 | -100.79 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | n/a | n/a | n/a | n/a |
Quick Ratio | 13.19 | 10.80 | 11.96 | 11.31 | 13.45 | 17.02 | 23.30 | 20.15 | 20.88 | 25.31 | 31.09 | 32.23 |
Current Ratio | 13.19 | 10.80 | 11.96 | 11.31 | 13.45 | 17.02 | 23.30 | 20.15 | 20.88 | 25.31 | 31.09 | 32.23 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | -66.16 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.11 | -0.18 | -0.16 | -0.14 | -0.13 | -0.12 | -0.1 | -0.09 | -0.08 | -0.07 | -0.06 | -0.05 |
Return on Assets | -0.1 | -0.16 | -0.15 | -0.13 | -0.11 | -0.1 | -0.08 | -0.08 | -0.07 | -0.06 | -0.05 | -0.05 |
Return on Invested Capital | -0.12 | -0.19 | -0.17 | -0.14 | -0.12 | -0.11 | -0.09 | -0.08 | -0.07 | -0.07 | -0.05 | -0.05 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |